当前位置:
X-MOL 学术
›
Eur. J. Pharmacol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
[3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe.
European Journal of Pharmacology ( IF 4.2 ) Pub Date : 2005-11-18 , DOI: 10.1016/j.ejphar.2005.09.063 Jinbin Xu 1 , Zhude Tu , Lynne A Jones , Suwanna Vangveravong , Kenneth T Wheeler , Robert H Mach
European Journal of Pharmacology ( IF 4.2 ) Pub Date : 2005-11-18 , DOI: 10.1016/j.ejphar.2005.09.063 Jinbin Xu 1 , Zhude Tu , Lynne A Jones , Suwanna Vangveravong , Kenneth T Wheeler , Robert H Mach
Affiliation
N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methyl-benzamide (RHM-1) and N-[2-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)ethyl]-2-methoxy-5-methylbenzamide (RHM-2), two conformationally flexible benzamide analogues, were radiolabeled with tritium (specific activity=80 Ci/mmol) and the binding of [3H]RHM-1 and [3H]RHM-2 to sigma-2 (sigma2) receptors was evaluated in vitro. [3H]RHM-1 was found to have a higher affinity for sigma2 receptors compared to [3H]RHM-2 and [3H]1,3-di-o-tolylguanidine ([3H]DTG). [3H]RHM-1 had a dissociation constant (Kd) of 0.66+/-0.12 nM in rat liver membrane homogenates, which was 30-fold higher than that of [3H]RHM-2 (Kd=19.48+/-0.51 nM). The lower affinity of [3H]RHM-2 can be attributed to its faster K(off) rate since both radioligands have similar K(on) rates. Competitive binding assays were also conducted using a panel of compounds with known affinity for sigma2 receptors. The pharmacologic profile of [3H]RHM-1 was in agreement with that of [3H]DTG. The results of this study indicate that [3H]RHM-1 is a useful ligand for studying sigma2 receptors in vitro.
中文翻译:
[3H] N- [4-(3,4-二氢-6,7-二甲氧基异喹啉-2(1H)-基)丁基] -2-甲氧基-5-甲基苯甲酰胺:新型sigma-2受体探针。
N- [4-(3,4-二氢-6,7-二甲氧基异喹啉-2(1H)-基)丁基] -2-甲氧基-5-甲基苯甲酰胺(RHM-1)和N- [2-(3 two具有放射性构象的两个构象灵活的苯甲酰胺类似物1,4-二氢-6,7-二甲氧基异喹啉-2(1H)-基)乙基] -2-甲氧基-5-甲基苯甲酰胺(RHM-2)(比活度= 80 Ci / mmol),并在体外评估[3H] RHM-1和[3H] RHM-2与sigma-2(sigma2)受体的结合。与[3H] RHM-2和[3H] 1,3-二-邻甲苯基胍([3H] DTG)相比,发现[3H] RHM-1对sigma2受体具有更高的亲和力。[3H] RHM-1在大鼠肝膜匀浆中的解离常数(Kd)为0.66 +/- 0.12 nM,比[3H] RHM-2的解离常数(Kd = 19.48 +/- 0.51 nM)高30倍)。[3H] RHM-2的较低亲和力可归因于其更快的K(off)速率,因为两个放射性配体的K(on)速率相似。还使用一组对sigma2受体具有已知亲和力的化合物进行竞争性结合测定。[3H] RHM-1的药理特性与[3H] DTG的一致。这项研究的结果表明[3H] RHM-1是用于研究sigma2受体的有用配体。
更新日期:2019-11-01
中文翻译:
[3H] N- [4-(3,4-二氢-6,7-二甲氧基异喹啉-2(1H)-基)丁基] -2-甲氧基-5-甲基苯甲酰胺:新型sigma-2受体探针。
N- [4-(3,4-二氢-6,7-二甲氧基异喹啉-2(1H)-基)丁基] -2-甲氧基-5-甲基苯甲酰胺(RHM-1)和N- [2-(3 two具有放射性构象的两个构象灵活的苯甲酰胺类似物1,4-二氢-6,7-二甲氧基异喹啉-2(1H)-基)乙基] -2-甲氧基-5-甲基苯甲酰胺(RHM-2)(比活度= 80 Ci / mmol),并在体外评估[3H] RHM-1和[3H] RHM-2与sigma-2(sigma2)受体的结合。与[3H] RHM-2和[3H] 1,3-二-邻甲苯基胍([3H] DTG)相比,发现[3H] RHM-1对sigma2受体具有更高的亲和力。[3H] RHM-1在大鼠肝膜匀浆中的解离常数(Kd)为0.66 +/- 0.12 nM,比[3H] RHM-2的解离常数(Kd = 19.48 +/- 0.51 nM)高30倍)。[3H] RHM-2的较低亲和力可归因于其更快的K(off)速率,因为两个放射性配体的K(on)速率相似。还使用一组对sigma2受体具有已知亲和力的化合物进行竞争性结合测定。[3H] RHM-1的药理特性与[3H] DTG的一致。这项研究的结果表明[3H] RHM-1是用于研究sigma2受体的有用配体。